Tracy Laabs

Dr. Tracy Laabs is the Head of Innovation and Strategic Partnerships at the Wyss Center for Bio and Neuroengineering, a leading Swiss non-profit focused on accelerating the translation of neuroscience and neurotechnology innovations into impactful clinical solutions. With over 18 years of experience at the intersection of science, technology, and business, Dr. Laabs leads initiatives to identify high-potential research opportunities and forge strategic alliances that drive growth and investment in the Centers science and technology. Her role includes shaping the Wyss Center’s innovation pipeline and building robust ecosystems with industry partners, investors, and academic collaborators to bring breakthrough technologies to market. She previously served as Chief Development Officer and Founding Deputy Director of the Wyss Center, playing a pivotal role in establishing the organization as a global leader in neurotechnology translation. During her ten year tenure, the Center scaled its portfolio, launched successful spin-offs, and expanded its international footprint. She currently serves on multiple advisory boards and holds board roles for several Wyss Center spin-out companies, contributing to strategic direction, fundraising, and operational growth. Earlier in her career, Dr. Laabs was a Senior Scientist at Strategic Analysis, Inc., supporting advanced R&D programs for the US Defense Advanced Research Projects Agency (DARPA) in areas spanning neuroscience, biotechnology, and human performance. Dr. Laabs brings deep expertise in multidisciplinary program development, high-risk/high-reward innovation strategies, and team leadership across academia, government, and the private sector. She is also a passionate advocate for science communication, entrepreneurship, and the mentorship of emerging leaders in the neurotechnology space. She holds a PhD in Clinical Neuroscience from the University of Cambridge and a BS in Pharmacology and Toxicology from the University of Wisconsin–Madison.